Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience.
Ferraresso
M
M
Division of Vascular Surgery and Organ Transplant, Policlinico-University Hospital, IRCCS, Milan, Italy.
Ghio
L
L
Edefonti
A
A
Garavaglia
R
R
Pozzoli
E
E
Berardinelli
L
L
D000208:Acute Disease; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007113:Immunity, Innate; D007165:Immunosuppression Therapy / Q000379:methods; D007674:Kidney Diseases / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D012189:Retrospective Studies; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use*
D011948:Receptors, Antigen, T-Cell; D016572:Cyclosporine; D011241:Prednisone; D016559:Tacrolimus; D008775:Methylprednisolone